The small peptides covered by the patent are more water-soluble and practically devoid of smell, Sabinsa says.
Sabinsa (East Windsor, NJ) has received a U.S. patent for the process of manufacturing small peptides that incorporate selenium, for pharmaceutical and cosmeceutical applications.
“New products, namely selenodipeptides, based upon the patent, will greatly expand the applications of selenium, an essential element for human nutrition and one in which people could be deficient,” the company stated in a press release.
The small peptides covered by the patent are more water-soluble and practically devoid of smell, Sabinsa says.
Sabinsa is a leader in selenium research for nutrition and cosmetics, with products including SeleniumSeLECT, SelenoForce, and Methyselene. Newer products PeptiSeLect and PeptiSelene will now be added.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.